Skip to content

A study to compare the effect of Polyherbal combination made from Brahmi, Shankhpushpi, and Vacha with Tagar powder in improving sleep in people suffering from insomnia.

Effectiveness of a polyherbal churn formulation of Bramhi, Shankhpushpi and Vacha compared to Tagar churn in the management of Anidra (Primary insomnia):A Randomised Controlled Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106301
Enrollment
80
Registered
2026-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition

Interventions

None listed

Sponsors

Dr Nikita Gajanan Deulkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 60 years 2. Diagnosed cases of Primary Insomnia based on Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-IV) 3. AIS score more than or equal to 6 at baseline. 4. Duration of insomnia more than or equal to 1 month 5. Willingness to participate and provide written informed consent

Exclusion criteria

Exclusion criteria: Secondary insomnia due to psychiatric disorders (e.g., depression, anxiety) or medical conditions. History of substance abuse or sedative use within the past 2 weeks. Severe hepatic, renal, or cardiovascular illness. Pregnant or lactating women. Known allergy to trial drugs or their components. Known case of Lactose Intolerance.

Design outcomes

Primary

MeasureTime frame
This study may provide improvement in sleep quality assessed by the Athens Insomnia Scale (AIS) score from baseline to after 30 days of treatment.Timepoint: At the end of 30 days (7th, 15th, 30th days)

Secondary

MeasureTime frame
Change in severity of associated symptoms (Angamarda, Shirogaurava, Glani, and Jrumbha) before and after 30 days of treatment.Timepoint: At the end of 30 days (7th, 15th, 30th days)

Countries

India

Contacts

Public ContactDr Nikita Gajanan Deulkar

Shri Ayurved Mahavidyalaya, Nagpur

dr.dachewar@gmail.com9822206312

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026